Abstract

HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retrospective Analysis of a Large Healthcare Claims Database in the United States.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Transfusion Burden and Outcomes in Patients with Low- or Unspecified-Grade Myelodysplastic Syndromes Treated with Erythropoiesis-Stimulating Agents: Analysis of a United States Commercial Claims Database
Jacqueline Bussolari ... Ravi Potluri
Blood | VOL. 128
Jacqueline Bussolari, et. al.Jacqueline Bussolari ... Ravi Potluri
02 Dec 2016
Real-World Retrospective Study of Non-Transfusion Dependent Patients with Myelodysplastic Syndromes Treated with Luspatercept: A Healthcare Claims Database Study
Enrico Zanardo ... Ali Mcbride
Blood | VOL. 142
Enrico Zanardo, et. al.Enrico Zanardo ... Ali Mcbride
28 Nov 2023
British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
Jonathan Kell ... Simon J Stanworth
British journal of haematology | VOL. 194
Jonathan Kell, et. al.Jonathan Kell ... Simon J Stanworth
27 Jun 2021
Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).
Amy J Davidoff ... Xuehua Ke
Blood | VOL. 116
Amy J Davidoff, et. al.Amy J Davidoff ... Xuehua Ke
19 Nov 2010
View more papers

More From: Journal of the National Comprehensive Cancer Network : JNCCN

Paper Title
Journal
Date
Author
Enhancing Readability of Online Patient-Facing Content: The Role of AI Chatbots in Improving Cancer Information Accessibility.
Andres A Abreu ... Patricio M Polanco
Journal of the National Comprehensive Cancer Network : JNCCN | VOL. -
Andres A Abreu, et. al.Andres A Abreu ... Patricio M Polanco
15 May 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
Ryan Ying Cong Tan ... Yoon-Sim Yap
Journal of the National Comprehensive Cancer Network : JNCCN | VOL. -
Ryan Ying Cong Tan, et. al.Ryan Ying Cong Tan ... Yoon-Sim Yap
14 May 2024
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.
Michele Borghesani ... Sara Cingarlini
Journal of the National Comprehensive Cancer Network : JNCCN | VOL. -
Michele Borghesani, et. al.Michele Borghesani ... Sara Cingarlini
14 May 2024
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center.
Harrys A Torres ... Anita K Ying
Journal of the National Comprehensive Cancer Network : JNCCN | VOL. -
Harrys A Torres, et. al.Harrys A Torres ... Anita K Ying
10 May 2024
View more papers